HCPCS Level II · Outpatient PPS (temporary codes)
C9096Injection, filgrastim-ayow, biosimilar, (releuko), 1 microgram
Terminated 09/30/2022
Source: CMS HCPCS quarterly update, October 2026. Page updated September 29, 2026.
About C9096
C9096 is an HCPCS Level II code in the C series (outpatient PPS (temporary codes)), describing injection, filgrastim-ayow, biosimilar, (releuko), 1 microgram.
It was added to HCPCS effective 07/01/2022, and its current record took effect 10/01/2022.
It was terminated on 09/30/2022 and can't be billed for later dates of service.
Its Medicare coverage code is "C", meaning coverage is left to the Medicare contractor's judgment.
Details
- Short description
- Inj, releuko, 1 mcg
- Date added
- 07/01/2022
- Action effective
- 10/01/2022
- Termination date
- 09/30/2022
- BETOS
- O1E
Related C90xx codes
Common questions about C9096
Is HCPCS C9096 still valid?
- No. C9096 was terminated on 09/30/2022.
Does Medicare cover C9096?
- Its coverage code is "C": coverage is left to the Medicare contractor's judgment. Check the local coverage determination for your region.